TSS
ABUS icon

Two Sigma Securities’s Arbutus Biopharma ABUS Stock Holding History

Two Sigma Securities’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,534
Closed -$52.4K – 1427
2025
Q3 		$52.4K Sell
11,534
-5,251
-31% -$19.3K 0.01% 982
2025
Q2 		$51.9K Buy
+16,785
New +$55.7K 0.01% 1110
2025
Q1 		– Sell
-19,475
Closed -$63.7K – 1403
2024
Q4 		$63.7K Buy
+19,475
New +$71.6K 0.01% 1159
2023
Q2 		– Sell
-21,235
Closed -$64.3K – 2724
2023
Q1 		$64.3K Buy
+21,235
New +$59.9K ﹤0.01% 2253
2018
Q1 		– Sell
-11,294
Closed -$57K – 2631
2017
Q4 		$57K Sell
11,294
-1,311
-10% -$7.68K ﹤0.01% 1510
2017
Q3 		$78K Buy
+12,605
New +$53.9K 0.01% 697

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return